Patent US4853324A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4853324A Expired / Lapsed US ⏱️ 0.0 years remaining

Liver assist device employing transformed cell lines

Assignee: Individual
•
Filing: 1986-11-17
•
Granted: 1989-08-01
•
Expires: 2006-11-17
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract An improved extracorporeal liver assist device and method is provided which employs a blood perfusion membrane cultured with initially transformed hepatocytes until a confluent monolayer is developed, whereupon the hepatocytes are reverted to the somatic phenotype for perfusion purposes. Use of transformed hepatocytes permits serial subculturing to maintain a clinical supply of cells for the patient, while the in vitro proliferation characteristics and loss of contact inhibition of the transformed hepatocytes ensures rapid cell division and layer formation on the perfusion membranes. Virally transformed, temperature sensitive hepatocytes are preferred so that reversion of the cells can be accomplished by temperature change. The transformed hepatocytes may be cultured on the exterior surfaces of multiple capillary membrane cartridges, and subsequently reverted by elevating the temperature thereof. During perfusion, the patient's blood is passed through the lumen of the capillaries, and dissolved molecular species (e.g., bilirubin) diffuse through the membrane to be taken up and metabolized by the hepatocytes. Bathing solution is simultaneously passed around the exterior of the capillary tubes to remove metabolic wastes from the hepatocytes.

Inventors

  • 👤 Joseph M. Viles
  • 👤 Paul V. Hart

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 15:43
CPC Classifications
A; A61; A61M; A61M1/00; A61M1/36; A61M1/3687; A61M1/3689; C; C12; C12N; C12N5/00; C12N5/06; C12N5/0602; C12N5/067; C12N5/0671; C12N2510/00

Claims Analysis

Total Claims: 10
Claim 1
Independent Claim 145 words
A method of preparing a semipermeable membrane presenting a pair of opposed faces for use as a liver assist device, said method comprising the steps of: providing a mass of priamry hepatocytes; reversibly transforming said hepatocytes to cause the hepatocytes to proliferate in vitro, and to decrease the contact inhibition thereof; culturing said reversibly transformed hepatocytes on one face of said membrane until at least a confluent monolayer of reversibly transformed hepatocytes is formed thereon, said culturing step comprising the steps of seeding said one face with an effective quantity of said reversibly transformed hepatocytes to form said confluent monolayer, and continuously circulating culture medium which supports the growth of said reversibly transformed hepatocytes into contact with the reversibly transformed hepatocytes for a period of from about 1 to 48 days; and causing said cultured, reversibly transformed hepatocytes to revert to the somatic phenotype thereof.
Claim 2
Independent Claim 145 words
A method of preparing a semipermeable membrane presenting a pair of opposed faces for use as a liver assist device, said method comprising the steps of: providing a mass of priamry hepatocytes; reversibly transforming said hepatocytes to cause the hepatocytes to proliferate in vitro, and to decrease the contact inhibition thereof; culturing said reversibly transformed hepatocytes on one face of said membrane until at least a confluent monolayer of reversibly transformed hepatocytes is formed thereon, said culturing step comprising the steps of seeding said one face with an effective quantity of said reversibly transformed hepatocytes to form said confluent monolayer, and continuously circulating culture medium which supports the growth of said reversibly transformed hepatocytes into contact with the reversibly transformed hepatocytes for a period of from about 1 to 48 days; and causing said cultured, reversibly transformed hepatocytes to revert to the somatic phenotype thereof.
Claim 3
Dependent Claim 22 words
The method of claim 1, said hepatocytes being taken from the species of organism for which the liver assist device is intended.
Claim 4
Dependent Claim 11 words
The method of claim 1, said hepatocytes being virally reversibly transformed.
Claim 5
Dependent Claim 18 words
The method of claim 1, said hepatocytes being human, and being virally reversibly transformed by Simian Virus 40.
Claim 6
Dependent Claim 19 words
The method of claim 1, said membrane comprising a tube, said one face being the exterior of said tube.
Claim 7
Dependent Claim 13 words
The method of claim 5, said membrane comprising a plurality of said tubes.
Claim 8
Dependent Claim 25 words
The method of claim 1, further comprising the step of additionally seeding said one face with fresh reversibly transformed hepatocytes after the initial seeding step.
Claim 9
Dependent Claim 34 words
The method of claim 1, said reversibly transformed hepatocytes being temperature sensitive, said reversion step comprising the step of elevating the temperature of the reversibly transformed hepatocytes to a temperature of about 41° C.
Claim 10
Dependent Claim 12 words
A semipermeable membrane prepared in accordance with the method of claim 1.

References Cited (Backward Citations)

US3489647A Cited
US4242459A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1992-07-31 1993-01-30 1993-08-01 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1996-07-31 1997-01-30 1997-08-01 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2000-07-31 2001-01-30 2001-08-01 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag